Free Trial

Evolus (EOLS) News Today

Evolus logo
$12.96 -0.14 (-1.07%)
(As of 12/4/2024 05:53 PM ET)
Evolus, Inc. stock logo
Walleye Capital LLC Invests $3.44 Million in Evolus, Inc. (NASDAQ:EOLS)
Walleye Capital LLC bought a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 212,209 shares of the company's stock, valued at approximately $3,43
Evolus, Inc. stock logo
Connor Clark & Lunn Investment Management Ltd. Buys New Stake in Evolus, Inc. (NASDAQ:EOLS)
Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 58,046 shares of the company's stock, valued at approximately $940,000
Evolus, Inc. stock logo
Evolus, Inc. (NASDAQ:EOLS) Stake Decreased by Great Point Partners LLC
Great Point Partners LLC reduced its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 52.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,170,000 shares of the company's stock after selling 1,281,772 shares during the period. Evolus makes up
Evolus, Inc. stock logo
Evolus (NASDAQ:EOLS) Trading Down 3.8% - Here's What Happened
Evolus (NASDAQ:EOLS) Trading Down 3.8% - Here's Why
Evolus, Inc. stock logo
Evolus, Inc. (NASDAQ:EOLS) Short Interest Up 8.8% in October
Evolus, Inc. (NASDAQ:EOLS - Get Free Report) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 5,430,000 shares, an increase of 8.8% from the October 15th total of 4,990,000 shares. Based on an average daily volume of 613,400 shares, the short-interest ratio is currently 8.9 days.
Evolus, Inc. stock logo
GSA Capital Partners LLP Buys 93,176 Shares of Evolus, Inc. (NASDAQ:EOLS)
GSA Capital Partners LLP grew its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 335.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 120,964 shares of the company's stock after purchasing
Stifel Nicolaus Sticks to Its Buy Rating for Evolus (EOLS)
Evolus, Inc. stock logo
Evolus (NASDAQ:EOLS) Shares Gap Down on Disappointing Earnings
Evolus (NASDAQ:EOLS) Shares Gap Down Following Weak Earnings
Evolus, Inc. stock logo
HC Wainwright Reiterates Buy Rating for Evolus (NASDAQ:EOLS)
HC Wainwright reissued a "buy" rating and issued a $27.00 price target on shares of Evolus in a research report on Thursday.
Evolus Reports Third Quarter 2024 Results
Evolus Gets EU Approval for Treatment of Wrinkles
Evolus, Inc. stock logo
Evolus (NASDAQ:EOLS) Earns Buy Rating from HC Wainwright
HC Wainwright reaffirmed a "buy" rating and set a $27.00 price target on shares of Evolus in a research report on Friday.
Evolus, Inc. stock logo
Evolus, Inc. (NASDAQ:EOLS) Shares Acquired by Rice Hall James & Associates LLC
Rice Hall James & Associates LLC boosted its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 6.3% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 904,900 shares of the company's stock after acquiring an additional 53,605 shares during the quarter.
Evolus, Inc. stock logo
Evolus (EOLS) to Release Earnings on Wednesday
Evolus (NASDAQ:EOLS) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=638774)
Evolus rewards patient loyalty program surpasses 1M enrolled consumers
Evolus, Inc. stock logo
Semanteon Capital Management LP Makes New $912,000 Investment in Evolus, Inc. (NASDAQ:EOLS)
Semanteon Capital Management LP acquired a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 56,313 shares of the company's stock, valued at appro
Evolus, Inc. stock logo
Evolus (NASDAQ:EOLS) Shares Down 6.2% - Here's Why
Evolus (NASDAQ:EOLS) Trading Down 6.2% - What's Next?
Evolus, Inc. stock logo
SG Americas Securities LLC Buys Shares of 38,447 Evolus, Inc. (NASDAQ:EOLS)
SG Americas Securities LLC bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 38,447 shares of the company's stock, valued at approximately $623,000. S
Evolus, Inc. stock logo
Evolus (NASDAQ:EOLS) Hits New 1-Year High - Time to Buy?
Evolus (NASDAQ:EOLS) Reaches New 52-Week High - Here's Why
Evolus, Inc. stock logo
Evolus, Inc. (NASDAQ:EOLS) Shares Sold by Millennium Management LLC
Millennium Management LLC decreased its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 899,377 shares of the company's stock after selling 36,996 shares during the quarter. Mill
Evolus, Inc. stock logo
Healthcare of Ontario Pension Plan Trust Fund Buys Shares of 122,200 Evolus, Inc. (NASDAQ:EOLS)
Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 122,200 shares of the company's stock, valued at appr
Evolus, Inc. stock logo
Evolus, Inc. to Post Q3 2024 Earnings of ($0.12) Per Share, HC Wainwright Forecasts (NASDAQ:EOLS)
Evolus, Inc. (NASDAQ:EOLS - Free Report) - Equities research analysts at HC Wainwright lowered their Q3 2024 earnings estimates for Evolus in a report released on Thursday, October 3rd. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of ($0.12) for the quar
Evolus, Inc. stock logo
Evolus (NASDAQ:EOLS) Trading Down 3.4% - Here's Why
Evolus (NASDAQ:EOLS) Trading Down 3.4% - Here's Why
Evolus, Inc. stock logo
Brokers Issue Forecasts for Evolus, Inc.'s Q4 2024 Earnings (NASDAQ:EOLS)
Evolus, Inc. (NASDAQ:EOLS - Free Report) - Stock analysts at HC Wainwright upped their Q4 2024 earnings per share (EPS) estimates for Evolus in a report issued on Thursday, October 3rd. HC Wainwright analyst D. Tsao now expects that the company will earn $0.01 per share for the quarter, up from t
Evolus, Inc. stock logo
HC Wainwright Reaffirms Buy Rating for Evolus (NASDAQ:EOLS)
HC Wainwright restated a "buy" rating and issued a $27.00 price target on shares of Evolus in a report on Thursday.
Evolus, Inc. stock logo
Stonepine Capital Management LLC Sells 1,016,745 Shares of Evolus, Inc. (NASDAQ:EOLS)
Stonepine Capital Management LLC decreased its position in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 38.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,657,611 shares of the company's stock after se
Evolus, Inc. stock logo
Armistice Capital LLC Takes Position in Evolus, Inc. (NASDAQ:EOLS)
Armistice Capital LLC purchased a new position in Evolus, Inc. (NASDAQ:EOLS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 360,000 shares of the company's stock, valued at approximately $3,906,000. Armistice Capital LLC owned about 0.
Evolus Inc (EVL.DU)
Evolus, Inc. stock logo
Bank of New York Mellon Corp Acquires 35,760 Shares of Evolus, Inc. (NASDAQ:EOLS)
Bank of New York Mellon Corp lifted its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 24.6% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 181,093 shares of the company's stock after acquiring an additional 35,760 shares during the q
Evolus’s Strategic Growth and Market Expansion Garner a Buy Rating
Evolus, Inc. stock logo
Evolus (NASDAQ:EOLS) Stock Rating Reaffirmed by Cantor Fitzgerald
Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Evolus in a report on Monday.
Get Evolus News Delivered to You Automatically

Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter.

"Start Earning Extra Income with Just $30" (Ad)

What if you could unlock a steady income stream from stocks priced under $30? Our new guide walks you through simple, effective options strategies designed for everyday investors. With step-by-step insights, you’ll learn how to transform familiar names like Ford and Intel into reliable monthly income generators.

Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income”

EOLS Media Mentions By Week

EOLS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EOLS
News Sentiment

1.81

0.79

Average
Medical
News Sentiment

EOLS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EOLS Articles
This Week

1

4

EOLS Articles
Average Week

Get Evolus News Delivered to You Automatically

Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:EOLS) was last updated on 12/5/2024 by MarketBeat.com Staff
From Our Partners